Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)
China · Delayed Price · Currency is CNY 12.58
-0.29 (-2.25%)
Sep 4, 2026, 3:04 PM CST
SHE:300601 Revenue
Shenzhen Kangtai Biological Products had revenue of 641.89M CNY in the quarter ending June 30, 2026, a decrease of -14.05%. This brings the company's revenue in the last twelve months to 2.55B, down -10.12% year-over-year. In the year 2025, Shenzhen Kangtai Biological Products had annual revenue of 2.67B with 0.81% growth.
Revenue (ttm)
2.55B
Revenue Growth
-10.12%
P/S Ratio
5.50
Revenue / Employee
1.31M
Employees
1,957
Market Cap
14.05B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.67B | 21.37M | 0.81% |
| Dec 31, 2024 | 2.65B | -825.72M | -23.75% |
| Dec 31, 2023 | 3.48B | 320.04M | 10.14% |
| Jan 1, 2023 | 3.16B | -494.69M | -13.55% |
| Jan 1, 2022 | 3.65B | 1.39B | 61.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.